Initiator Pharma: Exceeding Expectations - Redeye

Redeye revisits the Initiator Pharma equity story following the company’s continued clinical advancements and recent capital raise. As we continue to see a compelling case rooted in an exciting and growing pipeline, bolstered by strong management and a solid ownership base, we slightly raise our Base Case.

Länk till analysen i sin helhet: https://www.redeye.se/research/854458/initiator-pharma-exceeding-expectations?utm_source=finwire&utm_medium=RSS